Y-mAbs Therapeutics, Inc.
USE OF ANTI-B7H3 ANTIBODIES FOR TREATING CANCER IN THE CENTRAL NERVOUS SYSTEM

Last updated:

Abstract:

The presently disclosed subject matter provides uses of anti-B7H3 antibodies for treating cancers in the central nervous system (CNS), including tumors metastatic to CNS, and in particular leptomeningeal carcinomatosis.

Status:
Application
Type:

Utility

Filling date:

14 May 2018

Issue date:

25 Jun 2020